zinc sulfate has been researched along with HIV Coinfection in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Back, D; Boffito, M; Else, L; Gazzard, B; Jackson, A; Karolia, Z; Moyle, G; Ringner-Nackter, L; Seymour, N; Yapa, MH | 1 |
Beijnen, JH; Hillebrand, MJ; Huitema, AD; Mulder, JW; Rosing, H; Ter Heine, R; van Gorp, EC | 1 |
Green, JA; Lee, M; Lewin, SR; Paton, NI; Ravindran, TS; Wightman, F | 1 |
Fielder, LM; Harvey, VM; Kishor, SI | 1 |
1 review(s) available for zinc sulfate and HIV Coinfection
Article | Year |
---|---|
Necrolytic acral erythema: case report and review of the literature.
Topics: Adult; Diagnosis, Differential; Disease Progression; Erythema; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hypertension; Hypothyroidism; Necrosis; Zinc Sulfate | 2008 |
2 trial(s) available for zinc sulfate and HIV Coinfection
Article | Year |
---|---|
Coadministration of atazanavir-ritonavir and zinc sulfate: impact on hyperbilirubinemia and pharmacokinetics.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Area Under Curve; Atazanavir Sulfate; Bilirubin; Confidence Intervals; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Drug Tolerance; Female; HIV Infections; HIV-1; Humans; Hyperbilirubinemia; Male; Middle Aged; Oligopeptides; Pyridines; Ritonavir; Young Adult; Zinc Sulfate | 2013 |
A randomised controlled trial of oral zinc on the immune response to tuberculosis in HIV-infected patients.
Topics: Administration, Oral; Adult; Antibody Formation; Antigens, Bacterial; CD4-CD8 Ratio; Dietary Supplements; Double-Blind Method; Female; HIV Infections; Humans; Interferon-gamma; Male; Middle Aged; Mycobacterium tuberculosis; Receptors, Antigen, T-Cell; Viral Load; Zinc Sulfate | 2005 |
1 other study(ies) available for zinc sulfate and HIV Coinfection
Article | Year |
---|---|
Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry.
Topics: Acetonitriles; Antiviral Agents; Biological Assay; Calibration; Chromatography, High Pressure Liquid; Desiccation; Drug Monitoring; Drug Stability; Drug Storage; Freezing; HIV Infections; HIV Integrase Inhibitors; Humans; Leukocytes, Mononuclear; Methanol; Molecular Structure; Particle Size; Pyrrolidinones; Raltegravir Potassium; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solutions; Tandem Mass Spectrometry; Water; Zinc Sulfate | 2009 |